SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Select Sector SPDRHealth Care  (XLV) Trade Now »     Rate XLV  -  Discuss XLV  -  Add to Watch List         Graphic_subscribe

       Sector: Financial  >  Industry: Misc. Financial Services
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate XLV:



XLV Analysis & Videos »


XLV: Bull or Bear?

Healthcare ETFs Outpace the Market Graphic_rating_buy XLV
Rxlogo
76%
 -15.75%
in 20 days

Healthcare ETFs Outpace the Market


The accompanying table presents an analysis and statistics for the 28 healthcare ETFs listed at the Yahoo! Finance ETF Center. As a group, the healthcare ETFs outpaced the overall market in the past year by more than 10%, posting an average loss of 26.5% compared to a loss of 37.4% for the S&P 500 SPDR ETF (SPY). The best performing healthcare ETF was the Biotech HOLDRs (BBH), thanks to a buyout bid for top holding Genetech (DNA) and solid earnings results this year for the number two position, Amgen (AMGN).

The top three
...
By  Mike Havrilla   (-6.40%  risk: moderate)  11/01/08 Comment


Health IT Poised to Rebound on Prospects for Increased Spending Graphic_rating_buy XLV
Rxlogo
76%
 +0.15%
in 2 days
(closed on 11/01/08)

Health IT Poised to Rebound on Prospects for Increased Spending


As I wrote previously, both presidential candidates are bullish on the healthcare information technology industry – planning to increase spending and investment as a way to improve the quality of healthcare and reduce costs through automation and the widespread implementation of other technologies such as electronic prescribing and computerized medical records. The accompanying tables highlights the performance over the past year of the ETFI Health IT Index of 38 companies along with the top five
...
By  Mike Havrilla   (-6.40%  risk: moderate)  10/30/08 Comment


An Earnings Encore for Amgen? Graphic_rating_buy XLV
Rxlogo
76%
 +1.22%
in 8 days
(closed on 10/30/08)

An Earnings Encore for Amgen?


I think Amgen (AMGN) will beat consensus estimates for sales and profits again today when it reports after the market close, continuing the same trends as last quarter, including better than expected sales of embattled anemia drugs Aranesp and Epogen. Amgen reported 2Q08 results (see conference call transcript ) that beat consensus analyst estimates and raised its full-year [FY] guidance for earnings and revenue, thanks to much stronger-than-expected sales of its anemia drugs Aranesp and Epogen:

- 2Q08 Revenue +1% at $3.8 bi
...
By  Mike Havrilla   (-6.40%  risk: moderate)  10/22/08 Comment


Get free stock alert for XLV:
Your Email Address:


Global AnimalBiz Posts Loss, Outpaces Healthcare ETFs Graphic_rating_buy XLV
Rxlogo
76%
 +2.69%
in 5 days
(closed on 10/22/08)

Global AnimalBiz Posts Loss, Outpaces Healthcare ETFs


The ETFI Global AnimalBiz Index includes a total of 35 companies with market caps between $100 million to $10 billion U.S. Dollars, with a semi-active rating system which is rebalanced each quarter to choose the top 25 rated companies as active components. The index excludes all big pharma and diversified healthcare giants which have animal health segments such as Schering-Plough (Intervet), Novartis, Pfizer, Merck + Sanofi-Aventis joint venture (Merial), Wyeth (Fort Dodge), and Eli Lilly (Elanco). These comp
...
By  Mike Havrilla   (-6.40%  risk: moderate)  10/17/08 1 comment


Generic Drug Industry Outpaces Drug & Healthcare ETFs Graphic_rating_buy XLV
Rxlogo
76%
 -0.04%
in 2 days
(closed on 10/17/08)

Generic Drug Industry Outpaces Drug & Healthcare ETFs


The accompanying table presents statistics and the top five rated companies in the ETFI Global Generic Drug Index, which includes a total of 44 companies. Over the past year, generic drug companies have outpaced both the Healthcare Sector SPDR (XLV) and existing drug ETFs such as PowerShares Dynamic Pharma (PJP), Pharma HOLDRs (PPH), iShares Dow Jones US Pharma (IHE), and the S&P Pharma SPDR (XPH).

All of the top five rated generic drug companies and over two-thirds of the 44 companies in the index are b
...
By  Mike Havrilla   (-6.40%  risk: moderate)  10/15/08 Comment


Seven New ETF Opportunities Graphic_rating_buy XLV
Rxlogo
76%
 -18.61%
in 26 days
(closed on 10/15/08)

Seven New ETF Opportunities

Global Auto Industry Index & Top 5 Companies by Market Cap
Global Airline Index & Top 5 Companies by Market Cap

Global Health Info Tech Index & Top 5 Companies by Market Cap

Global Generic Drug Index & Top 5 Companies by Market Cap

NordiCaps Region Index & Top 10 Rated Companies
Global Railroad Index & Top 5 Companies by Market Cap
Global Tobacco Index & Top 5 Companies by Market Cap

The accompanying tables present an overview of new
...
By  Mike Havrilla   (-6.40%  risk: moderate)  09/19/08 1 comment


A Global AnimalBiz Index Graphic_rating_buy XLV
Rxlogo
76%
 -0.54%
in 15 days
(closed on 09/19/08)

A Global AnimalBiz Index


The accompanying tables present an overview of the market cap-weighted Global AnimalBiz Index, which includes 32 companies with market caps between $100 million to $10 billion US Dollars. The index excludes all big pharma and diversified healthcare giants which have animal health segments such as Schering-Plough (Intervet), Novartis, Pfizer, Merck + Sanofi-Aventis joint venture ( Merial ), Wyeth (Fort Dodge), and Eli Lilly (Elanco). These companies are excluded to make the index more leveraged to animal care as this segment typical
...
By  Mike Havrilla   (-6.40%  risk: moderate)  09/04/08 1 comment


A Global AnimalBiz Index Graphic_rating_buy XLV
Rxlogo
66%
 -29.67%
in 78 days

The accompanying tables present an overview of the market cap-weighted Global AnimalBiz Index, which includes 32 companies with market caps between $100 million to $10 billion US Dollars. The index excludes all big pharma and diversified healthcare giants which have animal health segments such as Schering-Plough (Intervet), Novartis, Pfizer, Merck + Sanofi-Aventis joint venture ( Merial ), Wyeth (Fort Dodge), and Eli Lilly (Elanco). These companies are excluded to make the index more leveraged to animal care as this segment typically represents only about 5% of their sales.
...
By  Mike Havrilla   (-5.47%  risk: conservative)  09/04/08 Comment


Get free stock alert for XLV:
Your Email Address:





People Bullish on XLV

Rxlogo
Mike Havrilla
Principal
76%
20 days ago

Rxlogo
Mike Havrilla
Associate
66%
2 mos ago

barbenzinc2000
Analyst
N/A
3 mos ago

ataussig
Analyst
20%
6 mos ago

celander
Analyst
36%
9 mos ago


People Bearish on XLV

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 29.65 +61.65% 160
2 Gerald Greene 21.24 +48.89% 50
3 The Big Bear 19.00 +49.44% 205
4 krprasad 17.77 +19.60% 4
5 David Young 15.63 +16.16% 6


POPULAR STOCKS
Symbol Company Name Sentiment
WM Washington Mutual Inc
JPM JPMorgan Chase & Co
F Ford Motor Company
WMT WalMart Stores Inc
GOOG Google Inc
JNJ Johnson & Johnson

TODAY'S HEADLINES

TODAY'S TOP PICKS

 


StreetInsider.com on XLV


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Select Sector SPDRHealth Care - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch